JP2022523530A5 - - Google Patents

Info

Publication number
JP2022523530A5
JP2022523530A5 JP2021550218A JP2021550218A JP2022523530A5 JP 2022523530 A5 JP2022523530 A5 JP 2022523530A5 JP 2021550218 A JP2021550218 A JP 2021550218A JP 2021550218 A JP2021550218 A JP 2021550218A JP 2022523530 A5 JP2022523530 A5 JP 2022523530A5
Authority
JP
Japan
Prior art keywords
pharmaceutical composition
composition according
human subject
once
administration
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
JP2021550218A
Other languages
English (en)
Japanese (ja)
Other versions
JP2022523530A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2020/020115 external-priority patent/WO2020176738A1/en
Publication of JP2022523530A publication Critical patent/JP2022523530A/ja
Publication of JP2022523530A5 publication Critical patent/JP2022523530A5/ja
Abandoned legal-status Critical Current

Links

JP2021550218A 2019-02-28 2020-02-27 化膿性汗腺炎の治療のための抗IL-α抗体 Abandoned JP2022523530A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201962811696P 2019-02-28 2019-02-28
US62/811,696 2019-02-28
PCT/US2020/020115 WO2020176738A1 (en) 2019-02-28 2020-02-27 Anti-il-alpha antibody for the treatment of hidradenitis suppurativa

Publications (2)

Publication Number Publication Date
JP2022523530A JP2022523530A (ja) 2022-04-25
JP2022523530A5 true JP2022523530A5 (https=) 2023-03-01

Family

ID=70110308

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2021550218A Abandoned JP2022523530A (ja) 2019-02-28 2020-02-27 化膿性汗腺炎の治療のための抗IL-α抗体

Country Status (11)

Country Link
US (1) US20200277370A1 (https=)
EP (1) EP3930752A1 (https=)
JP (1) JP2022523530A (https=)
KR (1) KR20210134927A (https=)
CN (1) CN113905760A (https=)
AU (1) AU2020228299A1 (https=)
BR (1) BR112021016845A2 (https=)
CA (1) CA3131011A1 (https=)
MX (1) MX2021010402A (https=)
TW (1) TW202045537A (https=)
WO (1) WO2020176738A1 (https=)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2582391B1 (en) 2010-06-18 2018-10-03 XBiotech, Inc Arthritis treatment
CA3095675A1 (en) 2020-10-07 2022-04-07 Xbiotech Inc. True human antibody specific for interleukin 1 alpha (il-1a)
CA3095676A1 (en) 2020-10-07 2022-04-07 Xbiotech Inc. True human antibody specific for interleukin 1 alpha (il-1a)
CA3095740A1 (en) 2020-10-07 2022-04-07 Xbiotech Inc. True human antibody specific for interleukin alpha (il-1a)
CA3095679A1 (en) 2020-10-07 2022-04-07 Xbiotech Inc. True human antibody specific for interleuken 1 alpha (il-1a)

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2285409B1 (en) 2008-05-30 2016-04-20 XBiotech, Inc Il-1 alpha antibodies
JP5812669B2 (ja) 2011-04-27 2015-11-17 キヤノン株式会社 画像処理装置および画像処理方法およびコンピュータプログラム。
US9545411B2 (en) 2012-11-02 2017-01-17 Repros Therapeutics Inc. Methods and compositions for treating progesterone-dependent conditions
WO2015187779A1 (en) 2014-06-03 2015-12-10 Xbiotech, Inc. Compositions and methods for treating and preventing staphylococcus aureus infections
EP3582813A4 (en) * 2017-02-16 2020-12-30 XBiotech, Inc TREATMENT OF SUPPURATIVE HIDRADENITIS

Similar Documents

Publication Publication Date Title
JP2022523530A5 (https=)
JP2022188083A5 (https=)
JP2020507587A5 (https=)
JP2017512193A5 (https=)
US8795657B2 (en) Combination pharmaceutical composition and methods of treating diseases or conditions associated with respiratory disease or condition
JP2013533858A5 (https=)
JP2022160685A5 (https=)
JP2024001125A (ja) Il-17アンタゴニストを用いて初発プラーク型乾癬を治療する方法
ÖzDEMIR et al. A randomized comparison of acitretin-narrow-band TL-01 phototherapy and acitretin-psoralen plus ultraviolet A for psoriasis
JP2015500822A5 (https=)
JP2017511316A5 (https=)
WO2023061472A1 (zh) 抗her2抗体药物偶联物和酪氨酸激酶抑制剂联合在制备治疗肿瘤的药物中的用途
JP2019521156A5 (https=)
JP2025501978A5 (https=)
JP2024517085A5 (https=)
CN116712539A (zh) 抗her2抗体药物偶联物和抗pd-1抗体联合在制备治疗肿瘤的药物中的用途
JP2005514414A5 (https=)
JP2023545084A5 (https=)
JP2021532176A5 (https=)
JP2022514561A5 (https=)
JP2022513029A5 (https=)
FI3359572T3 (fi) Menetelmä multippeliskleroosin hoitamiseksi
JP2024521105A5 (https=)
JP7410256B2 (ja) 化膿性汗腺炎の治療のための汎elr+cxcケモカイン抗体
JP2023538419A5 (https=)